Biotechnology News

Certara partners with NVIDIA to advance its open, integrated AI platform for drug discovery and development with the BioNeMo Agent Toolkit

Nu-Tek will present data showing how its animal-free culture media nutrients improve yield, enhance processes, and strengthen supply security at SIMB 2026.

Nu-Tek présentera des données démontrant comment ses nutriments pour milieux de culture sans composants d’origine animale améliorent le rendement, optimisent les procédés et renforcent la sécurité...

Nu-Tek wird Daten vorstellen, die zeigen, wie die tierfreien Nährstoffe für Kulturmedien die Ausbeute verbessern, Prozesse optimieren und die Versorgungssicherheit in der Bioproduktion stärken. ...

Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1

Vivani Medical entered into agreement with Novo Nordisk to evaluate its miniature subdermal semaglutide (GLP-1) implant for weight management

Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expand Commercial Opportunity Dyadic’s Ebola preparedness work highlights C1’s potentia

– Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 protocol — – FDA agreed that a single pivotal Phase 3...

Pivotal Phase 3 trial enrolls 850 patients, exceeding original projections Study completion on track: symptomatic data readout - Q1 2027, disease-modifying data readout - Q1 2028 Company positions...

WAYNE, Pa., July 07, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway...